0 participants
Testing of TAK228 (MLN0128, Sapanisertib) Plus Docetaxel to the Usual Standard of Care for Advanced Squamous Cell Lung Cancer (A Lung-MAP Treatment Trial)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2020-11-20
- Start Date:
- 2020-09-05
- Completion:
- 2025-10-31
Conditions
- Lung Squamous Cell Carcinoma
- Recurrent Lung Carcinoma
- Stage IV Lung Cancer AJCC v8
- Stage IVA Lung Cancer AJCC v8
- Stage IVB Lung Cancer AJCC v8
Interventions
- BIOLOGICAL
- DRUG
No Results Yet